Rotavirus outer capsid proteins and NSP4 enterotoxin (VP4/VP7/NSP4)

Rotavirus outer capsid proteins (VP4 and VP7) and the non-structural protein 4 (NSP4) are essential for the infectivity and pathogenicity of Rotavirus, the leading cause of severe diarrhea in children (Estes & Greenberg, 2013). VP4 is a spike protein responsible for cell attachment and penetration, while VP7 is a glycoprotein that forms the outer shell; both are the primary targets for neutralizing antibodies (Desselberger, 2014). NSP4 functions as a viral enterotoxin, disrupting calcium homeostasis and inducing secretory diarrhea through the activation of the enteric nervous system and phospholipase C pathways (Ball et al., 1996). Current therapeutic interventions primarily involve live-attenuated vaccines like Rotarix and RotaTeq, which elicit immune responses against these capsid proteins to prevent infection (Burnett et al., 2020). Research also explores anti-NSP4 antibodies and small molecules to mitigate the enterotoxin-induced symptoms of gastroenteritis (Vance et al., 2016).

Other names

VP4 spike proteinVP7 glycoproteinNSP4 viral enterotoxinRotavirus outer shell proteinsRotavirus VP4Rotavirus VP7Rotavirus NSP4

Vaccines induce neutralizing antibodies against VP4 and VP7 to prevent viral attachment and entry into host enterocytes. Antiviral agents like nitazoxanide inhibit viral replication, while experimental therapies target NSP4 to block its enterotoxic effects on calcium signaling and intestinal secretion.